• All Share : 51629.23
    UP 0.41%
    Top40 - (Tradeable) : 45069.02
    UP 0.45%
    Financial 15 : 14393.56
    UP 0.56%
    Industrial 25 : 67697.77
    DOWN -0.10%
    Resource 10 : 32578.11
    UP 1.76%

  • ZAR/USD : 13.9849
    UP 0.23%
    ZAR/GBP : 17.1164
    UP 0.37%
    ZAR/EUR : 15.2599
    UP 0.13%
    ZAR/JPY : 0.1346
    UP 0.67%
    ZAR/AUD : 10.6724
    UP 0.32%

  • Gold US$/oz : 1265.7
    UP 0.04%
    Platinum US$/oz : 931
    DOWN -0.21%
    Silver US$/oz : 17.5
    UP 0.06%
    Palladium US$/oz : 622
    DOWN -1.27%
    Brent Crude : 51.9
    UP 0.99%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Sat Oct 22 05:46:11 SAST 2016

One person brain-dead, five hospitalised after French drug trial mishap: minister

AFP | 15 January, 2016 13:21
French Health Minister Marisol Touraine. File photo

A "serious accident" during a drugs trial in France has left one person brain-dead and five hospitalised, Health Minister Marisol Touraine said.

She said the six had been taking part in a "trial of an oral medication being developed by a European laboratory" in Rennes, northwest France.

Media reports said the drug was a cannabis-based painkiller, but this was denied by the health ministry.

"A serious accident took place," the minister said, adding the study had been halted and all volunteers taking part recalled.

The study was a phase one clinical trial, in which healthy volunteers take the medication to "evaluate the safety of its use, tolerance and pharmacological profile of the molecule", the minister added in a statement.

Medical trials typically have three phases to assess a new drug or device for safety and effectiveness.

Phase I entails a small group of volunteers, and focuses only on safety.

Phase II and Phase III are progressively larger trials to assess the drug's effectiveness, although safety remains paramount.

The Paris prosecutor's office said an investigation had been opened.

Touraine said she was determined to "shed light on" what happened.


If you have an opinion you would like to share on this article, please send us an e-mail to the Times LIVE iLIVE team. In the mean time, click here to view the Times LIVE iLIVE section.